About Jussi Paananen
Jussi Paananen is CTO & Co-founder, director at SwitchPoint Bio Holding.
Experience
This experience comes from Jussi Paananen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jussi Paananen in the role, so the role may have started earlier or lasted longer.
SwitchPoint Bio Holding, Inc. Current
CTO & Co-founder, director
Chief Technology Officer, Co-Founder (2026 – Present)
2026 – Present · Wilmington, DE
Analyzes blood cell biology for drug developers and clinical researchers.
BH
Broad Institute of MIT and Harvard
Visiting Scientist
2006 – 2026
MH
Meru Health
Chief Technology Officer
2023 – 2024
QD
Quest Diagnostics
Executive Director
2020 – 2023
NO
Nursie Health Oy
Vice-Chairman Of The Board
2020 – 2021
BG
Blueprint Genetics
Chief Technology Officer
2017 – 2020
AT
Afekta Technologies
Chairman Of The Board
2017 – 2019
GL
Genomi Solutions Ltd.
Chairman Of The Board
2008 – 2019
TD
The Research Ethics Committee of the Northern Savo Hospital District
Member
2016 – 2018
UF
University of Eastern Finland
Research Manager (2003 – 2018)
Assistant Professor (2015 – 2018)
Senior Researcher (2013)
Bioinformatics Specialist (part-time) (2010 – 2013)
Bioinformatician (2011 – 2013)
2003 – 2018
KN
Kuopio University Hospital (KUH) / Neurosurgery
Researcher
2015
LO
La-Ti Palvelut Oy
Vice Member of the Board
1998 – 2012
UM
University of Kuopio, Institute of Clinical Medicine
Senior Researcher
2009 – 2010
UB
University of Kuopio, Deparment of Biosciences
Senior Bioinformatician
2008
UB
University of Kuopio, Department of Biosciences
Researcher/Doctoral student
2007 – 2008
KO
Kuopion Mikronikkarit Oy
Computer Engineer
1998 – 1999
Key Colleagues at Startups
The people Jussi Paananen works with at each company, as listed on that company's latest Form D.
SwitchPoint Bio Holding, Inc. · Form D, Mar 10, 2026
DP
David Proctor
Director
SM
Samuel Myllykangas
CEO & Co-founder, director